您的位置: 首页 > 农业专利 > 详情页

1-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for treating cancer
专利权人:
Eli Lilly and Company
发明人:
Bastian, Jolie Anne,Chen, Jiehao,Cohen, Jeffrey Daniel,Henry, James Robert,McMillen, William Thomas,Reaman, Bradley Earl,Rubio, Almudena,Sall, Daniel Jon,Zhao, Gaiying
申请号:
AU2017277833
公开号:
AU2017277833A1
申请日:
2017.05.31
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The present invention relates to certain novel 2,3-dihydro-1H-indole compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, more particularly for the treatment of cancer selected from the group consisting of melanoma, acute myeloid leukemia, chronic lymphocytic leukemia, colorectal cancer, breast cancer, lung cancer, ovarian cancer, fallopian tube carcinoma, primary peritoneal carcinoma, cervical cancer, gastric cancer, liver cancer, pancreatic cancer, thyroid cancer, glioblastoma, non- Hodgkin´s lymphoma, and Hodgkin´s lymphoma.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充